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A regioselective synthesis of 3-triﬂuoromethyl-1-phenyl-1H-pyrazoles (1,3-isomers) as well as their 1,5-
isomers (5-triﬂuoromethyl-1-phenyl-1H-pyrazoles), is described. The 1,3-isomers were obtained from
the reaction of 4-alkoxy-1,1,1-triﬂuoroalk-3-en-2-ones with arylhydrazones followed by deprotective
hydrolysis while the 1,5-isomer was obtained by direct cyclocondensation of 4-alkoxy-1,1,1-trif-
luoroalk-3-en-2-ones with phenylhydrazine. An unequivocal assignment of the 1,3- and 1,5-isomers of
the pyrazole products is given.
 2013 Elsevier Ltd. All rights reserved.Pyrazoles are an interesting class of the heteroaromatic ring
system because they exhibit important biological activities1 that
ﬁnd extensive application in agriculture,2 microbiology,3 and med-
icine4 ﬁelds. Additionally, it is well known that the insertion of
ﬂuorine and ﬂuorinated groups into organic molecules is often
associated with positive changes in their physical, chemical, and
biological proprieties.1c,5 Therefore, the development of efﬁcient
and regioselective methods for the synthesis of pyrazoles bearing
ﬂuorinated groups in their structures is of great interest.
The most general method employed in the preparation of trifu-
oromethylpyrazoles is the [3+2] cyclocondensation reaction be-
tween a triﬂuoromethylated CCC building block and a NN
building block.6 Among the starting materials available for the 3-
atom fragment, triﬂuoromethylated 1,3-diketones have been
widely employed and their use is considered a general approach
to the synthesis of these heterocycles. However, despite excellent
yields and widespread application, this method suffers from poor
regioselectivity and frequently affords a mixture of isomeric pyra-
zoles (Fig. 1).6,7
In previous Letters, we have demonstrated that the direct
cyclocondensation between triﬂuoromethylated enones and
phenylhydrazine is highly regioselective furnishing 1-substi-
tuted-5-triﬂuoromethyl-1H-pyrazoles (1,5-isomer, Fig. 1) as the
only product.8 In our estimation, the synthesis of 1-substituted-3-triﬂuoromethyl-1H-pyrazoles (1,3-isomer, Fig. 1) from these
precursors under classical reaction conditions is quite unusual,
having occurred in only two different occasions in the course of
our investigations.9 The high selectivity observed in those reac-
tions can be ascribed to the well deﬁned reactivity of the enones
(compounds 1–7, Scheme 1) which is mainly induced by the
electron ‘push–pull’ effect of the carbonyl (p-acceptor) and the
4-alkoxy or 4-amino groups (p-donor), as reported previously.10
Thus, as part of our research program we aimed to develop
novel synthetic strategies leading to the regioselective heterocycli-
zation of 4-alkoxy-1,1,1-triﬂuoro-3-alken-2-ones, we now wish to
report the synthesis of a series of 1-phenyl-3-triﬂuoromethyl-1H-
pyrazoles 16–22 (Scheme 1) under regiochemical control.
Additionally, in order to achieve a concise characterization of the
products, we have also synthesized the 1-phenyl-5-triﬂuoro-
methyl-1H-pyrazole isomers 23–29 (Scheme 1) for comparing
GC–MS and 1H and 13C NMR data.
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Scheme 1. Synthetic strategies leading to 1-phenyl-3(5)-triﬂuoromethyl-1H-pyr-
azoles from 4-alkoxy-1,1,1-triﬂuoro-3-alken-2-ones.
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oles (16–22) was envisioned using a two-step procedure that in-
volves: (a) the reaction of triﬂuoromethylated enones with
hydrazones derived from phenylhydrazine, and (b) hydrazone
acidic deprotection. This synthetic approach is believed to proceed
by a Michael addition–elimination of the hydrazones to the enones
followed by the deprotective hydrolysis of the hydrazone azome-
thine linkage, and subsequent intramolecular nucleophilic hetero-
cyclization (Scheme 1). In fact, we were actually able to isolate and
characterize some enaminone intermediates (9–15a–e) suggesting
that this reaction mechanism is probably plausible.
The reactions between enaminones and dinucleophiles address-
ing to heterocycles have been extensively reported.8d,11 In these
reactions, however, the amino group is frequently eliminated as
the ring closure takes place and, as a result, this group does not
take part in the ﬁnal heterocycle structure. Thus, the use of hydra-
zone reagents for the regioselective synthesis of pyrazoles remains
underexplored.12
Scheme 2 outlines the synthesis of novel enaminones 9a–e from
the Michael addition–elimination reaction of hydrazones (8a–e) to
4-alkoxy-1,1,1-triﬂuoro-3-alken-2-ones. These reactions were
monitored by thin-layer chromatography by following the disap-
pearance of the enone.
The structures of the enaminones 9a–e were examined by 1H
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Scheme 2.and/or elemental analysis were registered to conﬁrm the purity
of compounds. Additionally, in order to unequivocally assign the
stereochemistry of the enaminones 9, the crystal structure of com-
pound 9dwas determined by single-crystal X-ray diffraction. Crys-
tals suitable for X-ray diffraction were obtained by slow
evaporation of chloroform solutions of compound 9d.13 Crystallo-
graphic analysis revealed that both C–C double bond and benzy-
liminic moiety exhibit an (E)-conﬁguration. In the course of our
investigations, we observed that enaminone intermediates 10–
15a–e spontaneously decomposed to the corresponding pyrazole
after isolation. Therefore, a complete characterization was
unpractical.
Acid hydrolysis of the azomethine linkage of enaminones 9a–e
afforded the 3-triﬂuoromethyl-1-phenyl-1H-pyrazole 1614 as the
only product in good yields (entries 1–5, Table 1). Reactions were
carried out by stirring a solution of selected enaminones 9a–ewith
hydrochloric acid in acetonitrile at room temperature for 1 h
(method A, Table 1). The best hydrolysis condition was achieved
when 2 equiv of concentrated hydrochloric acid was employed.
Aqueous solutions of hydrochloric acid and basic reaction condi-
tions were also tested, but did not furnish a complete conversion
to the pyrazole.
Pyrazole 1714 was isolated after stirring enone 2 with hydra-
zones 8a–e in chloroform for 24 h at room temperature followed
by the addition of 2 equiv of hydrochloric acid, and stirring for
an additional hour (method B, Table 1). Unfortunately, these reac-
tions always afforded a small amount of the 1,5-pyrazole regio-
isomer, compound 24 (entries 6–10, Table 1).
It was also not possible to isolate enaminone 11a–e because the
pyrazole 1814 was directly obtained after stirring the reaction in
chloroform under reﬂux for 24 h (method C, Table 1). Apparently,
the hydrolysis of the intermediate was accomplished simply by
heating the solution, thus, the addition of hydrochloric acid was
not required for the cyclization step.
Finally, pyrazoles 19–22 were obtained with high regioselectiv-
ity from hydrazone 8a using the same method as compound 17
(entries 16–19, method B, Table 1).
The results shown in Table 1 imply that the presence of differ-
ent groups attached to the benzylidene portion of hydrazones 8a–e
do not indicate a great inﬂuence on the reaction yields and times,
but it may have a small effect on the regioisomer proportion. The
ratio of isomers was determined by integration of the GC–MS total
ion chromatograms (Table 1).
To further conﬁrm the correct isomer assignment, direct
cyclization of enones 1–7 with phenylhydrazine was carried out
to obtain preferentially 5-triﬂuoromethyl-1-phenyl-1H-pyrazoles
(1,5-isomer). Table 2 shows the reaction conditions, yields and pro-
portion of 1,3- and 1,5-isomers. The results state that the direct
cyclization of enones 1–7 with phenylhydrazine furnished the
1,5-isomer of pyrazoles with high regioselectivity, as expected.15
In addition, by having both isomers in hands, it was easy to estab-
lish unequivocally the 1H and 13C NMR and GC–MS spectral data of
each regioisomer. In particular, GC–MS was very useful for assign-
ing the 1,3- and 1,5-isomers of pyrazoles since each one eluted
from the capillary column in different retention times allowing a
simple and direct comparison. This trend was the simplest, fastest,
and reliable information for assigning the correct structure of the
title compounds.
The structure assignment of the pyrazole isomers was also sup-
ported by the study done by Laurent et al., which described the
synthesis of both 1,5-diphenyl-3(5)-triﬂuoromethyl-1H-pyrazoles
18 and 25 from the reaction of b-chloro-b-triﬂuoromethylenone
and phenylhydrazine.16 1H and 13C NMR chemical shifts of their
compounds are in agreement with the data collected from our pyr-
azoles. Data from our previous study was also helpful for the con-
ﬁrmation of the 5-triﬂuormethyl-1-phenyl-1H-pyrazoles.15
Table 1
Reaction conditions and yields for the synthesis of 1-phenyl-3-triﬂuoromethyl-1H-pyrazoles (16–22)
Entry Enone R R1 R2 Hydrazone Ar Method Yielda (%) Pyrazole Isomer 1,3:1,5b
1 1 Et H H 8a C6H5 A 87 16 100:0
2 1 Et H H 8b 2-OH–C6H4 A 76 16 100:0
3 1 Et H H 8c 4-OMe–C6H4 A 82 16 100:0
4 1 Et H H 8d 4-NO2–C6H4 A 91 16 100:0
5 1 Et H H 8e 4-OH–C6H4 A 63 16 100:0
6 2 Et H Me 8a C6H5 B 84 17+24 87:13
7 2 Et H Me 8b 2-OH–C6H4 B 76 17+24 85:15
8 2 Et H Me 8c 4-OMe–C6H4 B 82 17+24 83:17
9 2 Et H Me 8d 4-NO2–C6H4 B 72 17+24 90:10
10 2 Et H Me 8e 4-OH–C6H4 B 74 17+24 94: 6
11 3 Me C6H5 H 8a C6H5 C 87 18 100:0
12 3 Me C6H5 H 8b 2-OH–C6H4 C 56 18 100:0
13 3 Me C6H5 H 8c 4-OMe–C6H4 C 60 18 100:0
14 3 Me C6H5 H 8d 4-NO2–C6H4 C 40 18 100:0
15 3 Me C6H5 H 8e 4-OH–C6H4 C 63 18 100:0
16 4 Me 4-MeC6H4 H 8a C6H5 B 78 19 100:0
17 5 Me 4-MeOC6H4 H 8a C6H5 B 76 20+27 88:12
18 6 Me 4-FC6H4 H 8a C6H5 B 81 21+28 97:3
19 7 Me 2-Furyl H 8a C6H5 B 75 22 100:0
Reaction conditions: method A: (1) CHCl3, rt, 4 h. (2) MeCN, HCl, 2.0 equiv, rt, 1 h; method B: (1) CHCl3, rt, 24 h. (2) HCl, 2.0 equiv, rt, 1 h; method C: CHCl3, reﬂux, 24 h.
a Yields of isolated compounds.
b Isomeric proportion calculated from the GC/MS total ion chromatogram.
Table 2
Proportion of 1,3- versus 1,5-isomers of N-phenyl pyrazoles from the direct
condensation between enones 1–4 and phenylhydrazine (‘classical approach’)
Enone R R1 R2 Yielda (%) Pyrazole Isomerb (1,3:1,5)
1 Et H H 90 16+23 12:88
2 Et H Me 79 17+24 2:98
3 Me C6H5 H 87 18+25 1:99
4 Me 4-MeC6H5 H 90 19+26 0:100
5 Me 4-MeOC6H5 H 94 20+27 0:100
6 Me 4-FC6H5 H 95 21+28 1:99
7 Me 2-Furyl H 78 22+29 0:100
a Yields of isolated compounds.
b Reaction conditions: PhNHNH2, MeCN, reﬂux, 24 h.
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1-phenyl-3-triﬂuoromethyl-1H-pyrazoles from 4-alkoxy-1,1,1-tri-
ﬂuoro-3-alken-2-ones using a simple and efﬁcient one pot method.
The desired triﬂuoromethylpyrazoles were easily prepared in a
two-step procedure that involved the reaction of enones with
hydrazones derived from phenylhydrazine and commercially
available aldehydes, followed by deprotective hydrolysis of the
hydrazone azomethine linkage, and subsequent intramolecular
nucleophilic heterocyclization. Additionally, a series of novel (E)-
4-(N0-benzylidene-N-phenyl-hydrazino)-1,1,1-triﬂuoro-but-3-en-
2-ones was obtained in good to excellent yields. A series of 1,5-pyr-
azole isomers was synthesized from the direct cyclization of enon-
es and phenylhydrazine (‘classical approach’) to provide an
unequivocal assignment of the obtained products. Thus, by com-
bining the method developed in this study with the direct cyclo-
condensation of enones one can obtain both 1,3- and 1,5-isomers
of pyrazole under regioselective control.
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7.32–7.29 (m, 2H, Ph), 6.82 (d, 2H, J = 8.80 Hz, Ph), 6.68 (s, 1H, H-4), 3.79 (s, 3H,
OMe); 13C NMR (100 MHz, CDCl3) d 160.1 (Ph), 144.5 (C-5), 143.1 (q,
1JCF = 38.5 Hz, C-3), 139.5 (Ph), 130.1 (Ph), 129.0 (Ph), 128.3 (Ph), 125.5 (Ph),
121.5 (Ph), 120.8 (q, 2JCF = 268.5 Hz, CF3) 114.1 (Ph), 104.9 (C-4), 55.23 (OMe);
MS-EI (m/z): 318 (100, M+), 303 (20), 275 (7), 205 (7), 77 (17). HRMS-ESI: MH+
calcd for C17H14F3N2O, 319.1058; found: 319.1056.
3-Triﬂuoromethyl-1-phenyl-5-(4-ﬂuorophenyl)-1H-pyrazole (21): brown oil 1H
NMR (400 MHz, CDCl3) d 7.35–7.34 (m, 2H, Ph), 7.29–7.27 (m, 2H, Ph), 7.20 –
7.17 (m, 3H, Ph), 6.99 (m, 2H, Ph), 6.70 (s, 1H, H-4); 13C NMR (100 MHz, CDCl3)
d 161.7 (Ph), 143.6 (C-5), 143.2 (q, 2JCF = 38.1 Hz, C-3), 139.0 (Ph), 130.7 (d,
J = 8.1 Hz, Ph), 130.1 (Ph), 129.2 (Ph), 128.6 (Ph), 125.5 (Ph), 121.2 (q,
1JCF = 269.3 Hz, CF3), 115.8 (d, J = 22.0 Hz, Ph), 105.5 (C-4); MS-EI (m/z): 306
(100, M+), 285 (46), 237 (6), 77 (9). HRMS-ESI: MH+ calcd for C16H11F4N2,
307.0858; found: 307.0856.
3-Triﬂuoromethyl-1-phenyl-5-(2-furyl)-1H-pyrazole (22): brown oil 1H NMR
(400 MHz, CDCl3) d 7.48–7.47 (m, 3H, Ph), 7.43–7.40 (m, 2H, Ph), 7.41–7.39 (m,
1H, furyl), 6.89 (s, 1H, H-4), 6.32 (dd, J = 3.42 Hz, 1,66 Hz, 1H, furyl), 6.97 (d, 1H,
J = 3.42 Hz, furyl). 13C NMR (100 MHz, CDCl3) d 143.2 (C-furyl), 143.1 (q,
2JCF = 38.4 Hz, C-3), 139.4 (furyl), 136.2 (Ph), 130.2 (C-5), 129.4 (Ph), 129.2 (Ph),
126.1 (Ph), 121.7 (q, 1JCF = 269,3 Hz, CF3), 111.4 (C-furyl), 109.8 (C-furyl), 103.8
(C-4); MS-EI (m/z): 278 (100, M+), 249 (12), 224 (8), 77 (4). HRMS-ESI: MH+
calcd for C14H9F3N2ONa, 301.0565; found: 301.0560.
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